Molecule

Pazopanib

21 brands of Pazopanib in stock, compared side by side.

We stock 21 brands of Pazopanib (tablet; 200 Mg and 400 mg). The lowest per-unit price is USD $ 0.93, for Pazonat 400mg Tablet. Every brand listed is prescription-only: you can upload your prescription at checkout or from your account.

Brands of this molecule, with strength, pack size and price
Brand Strength Pack Price Per unit Availability
Pazib 200 Mg Tablet 200 Mg 30 Tablets USD $ 30.00 USD $ 1.00 In stock
Pazoci 200 Mg Tablet 200 Mg 30 Tablets USD $ 30.00 USD $ 1.00 In stock
Bdpazo 200 Mg Tablet 200 Mg 30 Tablets USD $ 30.00 USD $ 1.00 In stock
Pazolit 200 Mg Tablet 200 Mg 30 Tablets USD $ 30.00 USD $ 1.00 In stock
Pazotab 200 Mg Tablet 200 Mg 30 Tablets USD $ 59.00 USD $ 1.97 In stock
Pazolong 200 Mg Tablet 200 Mg 30 Tablets USD $ 60.00 USD $ 2.00 In stock
Biopanib 200 Mg Tablet 200 Mg 30 Tablets USD $ 73.00 USD $ 2.43 In stock
Pazeqol 200 Mg Tablet 200 Mg 30 Tablets USD $ 85.00 USD $ 2.83 In stock
Pazliz 200 Mg Tablet 200 Mg 30 Tablets USD $ 130.00 USD $ 4.33 In stock
Votrient 200 Mg Tablets 200 Mg 30 Tablets USD $ 201.00 USD $ 6.70 In stock
Pazonat 400mg Tablet 400 mg 30 Tablets USD $ 28.00 USD $ 0.93 In stock
Pazib 400 Mg Tablet 400 mg 30 Tablets USD $ 60.00 USD $ 2.00 In stock
Pazoci 400 Mg Tablet 400 mg 30 Tablets USD $ 60.00 USD $ 2.00 In stock
Bdpazo 400 Mg Tablet 400 mg 30 Tablets USD $ 60.00 USD $ 2.00 In stock
Pazolit 400 Mg Tablet 400 mg 30 Tablets USD $ 60.00 USD $ 2.00 In stock
Pazolong 400 Mg Tablet 400 mg 30 Tablets USD $ 79.00 USD $ 2.63 In stock
Pazotab 400 Mg Tablet 400 mg 30 Tablets USD $ 118.00 USD $ 3.93 In stock
Biopanib 400 Mg Tablet 400 mg 30 Tablets USD $ 146.00 USD $ 4.87 In stock
Pazliz 400 Mg Tablet 400 mg 30 Tablets USD $ 150.00 USD $ 5.00 In stock
Pazeqol 400 Mg Tablet 400 mg 30 Tablets USD $ 170.00 USD $ 5.67 In stock
Votrient 400 Mg Tablets 400 mg 30 Tablets USD $ 479.00 USD $ 15.97 In stock

About Pazopanib

Pazopanib is an oral multi-targeted tyrosine kinase inhibitor (TKI) approved for the treatment of advanced renal cell carcinoma (kidney cancer) and advanced soft tissue sarcoma. It works by blocking vascular endothelial growth factor receptors (VEGFR), platelet-derived growth factor receptors (PDGFR), and c-Kit, thereby cutting off the blood supply tumours need to grow.

Marketed as Votrient, pazopanib is taken as a once-daily oral tablet. In renal cell carcinoma, it is used as a first-line treatment for advanced or metastatic disease with demonstrated efficacy comparable to sunitinib but with a different tolerability profile. Indian generic versions are available in 200 mg and 400 mg tablet strengths.

At a glance

Brands in stock
21
Strengths
200 Mg / 400 mg
From
USD $ 28.00